Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/210000
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGriñán Ferré, Christian-
dc.contributor.authorJarné-Ferrer, Júlia-
dc.contributor.authorBellver-Sanchis, Aina-
dc.contributor.authorRibalta Vilella, Marta-
dc.contributor.authorBarroso Fernández, Emma-
dc.contributor.authorSalvador, Jesús M.-
dc.contributor.authorJurado Aguilar, Javier-
dc.contributor.authorPalomer Tarridas, Francesc Xavier-
dc.contributor.authorVázquez Carrera, Manuel-
dc.contributor.authorPallàs i Llibería, Mercè, 1964--
dc.date.accessioned2024-04-16T07:38:42Z-
dc.date.available2024-04-16T07:38:42Z-
dc.date.issued2024-02-23-
dc.identifier.issn1661-6596-
dc.identifier.urihttp://hdl.handle.net/2445/210000-
dc.description.abstract<p><em>Gadd45 genes have been implicated in survival mechanisms, including apoptosis, autophagy,</em></p><p><em>cell cycle arrest, and DNA repair, which are processes related to aging and life span. Here, we</em></p><p><em>analyzed if the deletion of Gadd45a activates pathways involved in neurodegenerative disorders such</em></p><p><em>as Alzheimer’s Disease (AD). This study used wild-type (WT) and Gadd45a knockout (Gadd45a−/−)</em></p><p><em>mice to evaluate AD progression. Behavioral tests showed that Gadd45a−/− mice presented lower</em></p><p><em>working and spatial memory, pointing out an apparent cognitive impairment compared with WT</em></p><p><em>animals, accompanied by an increase in Tau hyperphosphorylation and the levels of kinases involved</em></p><p><em>in its phosphorylation in the hippocampus. Moreover, Gadd45a−/− animals significantly increased the</em></p><p><em>brain’s pro-inflammatory cytokines and modified autophagy markers. Notably, neurotrophins and</em></p><p><em>the dendritic spine length of the neurons were reduced in Gadd45a−/− mice, which could contribute</em></p><p><em>to the cognitive alterations observed in these animals. Overall, these findings demonstrate that the</em></p><p><em>lack of the Gadd45a gene activates several pathways that exacerbate AD pathology, suggesting that</em></p><p><em>promoting this protein’s expression or function might be a promising therapeutic strategy to slow</em></p><p><em>down AD progression.</em></p>-
dc.format.extent1 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a:-
dc.relation.ispartofInternational Journal of Molecular Sciences, 2024-
dc.rightscc-by (c) Griñán-Ferré C et al., 2024-
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationMalaltia d'Alzheimer-
dc.subject.classificationMalalties neurodegeneratives-
dc.subject.classificationEpigenètica-
dc.subject.otherAlzheimer's disease-
dc.subject.otherNeurodegenerative Diseases-
dc.subject.otherEpigenetics-
dc.titleDeletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks.-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec747771-
dc.date.updated2024-04-16T07:38:47Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
858356.pdf3.86 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons